These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 35569249)

  • 21. Increased NOD2-mediated recognition of N-glycolyl muramyl dipeptide.
    Coulombe F; Divangahi M; Veyrier F; de Léséleuc L; Gleason JL; Yang Y; Kelliher MA; Pandey AK; Sassetti CM; Reed MB; Behr MA
    J Exp Med; 2009 Aug; 206(8):1709-16. PubMed ID: 19581406
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Immunoadjuvant effects of the synthetic muramyl-dipeptide (MDP) N-acetylmuramyl-L-alanyl-D-isoglutamine.
    Heymer B; Finger H; Wirsing CH
    Z Immunitatsforsch Immunobiol; 1978 Oct; 155(1):87-92. PubMed ID: 706536
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A solid-phase approach for the synthesis of muramyl dipeptide conjugates for detection of NOD2.
    Kekessie I; Goncharov T; Kőműves LG; Vucic D; Song A
    Bioorg Chem; 2021 Nov; 116():105360. PubMed ID: 34562676
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Muramyl dipeptide enhances osteoclast formation induced by lipopolysaccharide, IL-1 alpha, and TNF-alpha through nucleotide-binding oligomerization domain 2-mediated signaling in osteoblasts.
    Yang S; Takahashi N; Yamashita T; Sato N; Takahashi M; Mogi M; Uematsu T; Kobayashi Y; Nakamichi Y; Takeda K; Akira S; Takada H; Udagawa N; Furusawa K
    J Immunol; 2005 Aug; 175(3):1956-64. PubMed ID: 16034140
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Human endothelial cells express NOD2/CARD15 and increase IL-6 secretion in response to muramyl dipeptide.
    Davey MP; Martin TM; Planck SR; Lee J; Zamora D; Rosenbaum JT
    Microvasc Res; 2006 Mar; 71(2):103-7. PubMed ID: 16414084
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Structural Fine-Tuning of Desmuramylpeptide NOD2 Agonists Defines Their
    Guzelj S; Nabergoj S; Gobec M; Pajk S; Klančič V; Slütter B; Frkanec R; Štimac A; Šket P; Plavec J; Mlinarič-Raščan I; Jakopin Ž
    J Med Chem; 2021 Jun; 64(11):7809-7838. PubMed ID: 34043358
    [TBL] [Abstract][Full Text] [Related]  

  • 27. MDP-Induced selective tolerance to TLR4 ligands: impairment in NOD2 mutant Crohn's disease patients.
    Cantó E; Moga E; Ricart E; Garcia-Bosch O; Garcia-Planella E; Juarez C; Vidal S
    Inflamm Bowel Dis; 2009 Nov; 15(11):1686-96. PubMed ID: 19572373
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Modulation of adaptive immunity by different adjuvant-antigen combinations in mice lacking Nod2.
    Moreira LO; Smith AM; DeFreitas AA; Qualls JE; El Kasmi KC; Murray PJ
    Vaccine; 2008 Oct; 26(46):5808-13. PubMed ID: 18789992
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Well-defined and potent liposomal hepatitis B vaccines adjuvanted with lipophilic MDP derivatives.
    Jain V; Vyas SP; Kohli DV
    Nanomedicine; 2009 Sep; 5(3):334-44. PubMed ID: 19523433
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Antagonizing NOD2 Signaling with Conjugates of Paclitaxel and Muramyl Dipeptide Derivatives Sensitizes Paclitaxel Therapy and Significantly Prevents Tumor Metastasis.
    Dong Y; Wang S; Wang C; Li Z; Ma Y; Liu G
    J Med Chem; 2017 Feb; 60(3):1219-1224. PubMed ID: 28075581
    [TBL] [Abstract][Full Text] [Related]  

  • 31. N-acetyl muramyl dipeptide stimulation of bone resorption in tissue culture.
    Dewhirst FE
    Infect Immun; 1982 Jan; 35(1):133-7. PubMed ID: 7054120
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Pro-inflammatory adjuvant properties of pigment-grade titanium dioxide particles are augmented by a genotype that potentiates interleukin 1β processing.
    Riedle S; Pele LC; Otter DE; Hewitt RE; Singh H; Roy NC; Powell JJ
    Part Fibre Toxicol; 2017 Dec; 14(1):51. PubMed ID: 29216926
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Immunostimulant activities of a lipophilic muramyl dipeptide derivative and of desmuramyl peptidolipid analogs.
    Parant MA; Audibert FM; Chedid LA; Level MR; Lefrancier PL; Choay JP; Lederer E
    Infect Immun; 1980 Mar; 27(3):826-31. PubMed ID: 7380554
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Molecular Recognition of Muramyl Dipeptide Occurs in the Leucine-rich Repeat Domain of Nod2.
    Lauro ML; D'Ambrosio EA; Bahnson BJ; Grimes CL
    ACS Infect Dis; 2017 Apr; 3(4):264-270. PubMed ID: 27748583
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Surface calreticulin mediates muramyl dipeptide-induced apoptosis in RK13 cells.
    Chen D; Texada DE; Duggan C; Liang C; Reden TB; Kooragayala LM; Langford MP
    J Biol Chem; 2005 Jun; 280(23):22425-36. PubMed ID: 15817475
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Peptidoglycan and muramyl dipeptide from Staphylococcus aureus induce the expression of VEGF-A in human limbal fibroblasts with the participation of TLR2-NFκB and NOD2-EGFR.
    Juárez-Verdayes MA; Rodríguez-Martínez S; Cancino-Diaz ME; Cancino-Diaz JC
    Graefes Arch Clin Exp Ophthalmol; 2013 Jan; 251(1):53-62. PubMed ID: 22890731
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Muramyl Dipeptide Enhances Thermal Injury-Induced Autophagy and Inflammatory Cytokine Response of Lungs via Activation of NOD2/Rick Signaling Pathway in Rats.
    Wu XJ; Liang H; Zhang Y; Yang XM; Wang HY; Li H; Li XY; Chen K; Wang YL; Li JG; Zhang ZZ; Song XM
    Shock; 2018 Nov; 50(5):606-612. PubMed ID: 29215417
    [TBL] [Abstract][Full Text] [Related]  

  • 38. NOD2 transgenic mice exhibit enhanced MDP-mediated down-regulation of TLR2 responses and resistance to colitis induction.
    Yang Z; Fuss IJ; Watanabe T; Asano N; Davey MP; Rosenbaum JT; Strober W; Kitani A
    Gastroenterology; 2007 Nov; 133(5):1510-21. PubMed ID: 17915219
    [TBL] [Abstract][Full Text] [Related]  

  • 39. NOD2 Mediates Odontoblast Differentiation and RANKL Expression.
    Lee SI; Kim GT; Kim HJ; Park SH; Kim EC
    J Dent Res; 2014 Jul; 93(7):678-84. PubMed ID: 24820666
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Synergistic effects of NOD1 or NOD2 and TLR4 activation on mouse sickness behavior in relation to immune and brain activity markers.
    Farzi A; Reichmann F; Meinitzer A; Mayerhofer R; Jain P; Hassan AM; Fröhlich EE; Wagner K; Painsipp E; Rinner B; Holzer P
    Brain Behav Immun; 2015 Feb; 44():106-20. PubMed ID: 25218901
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.